These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8275696

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The influence of copper surface area on menstrual blood loss and iron status in women fitted with an IUD.
    Milsom I, Rybo G, Lindstedt G.
    Contraception; 1990 Mar; 41(3):271-81. PubMed ID: 2323218
    [Abstract] [Full Text] [Related]

  • 3. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status.
    Milsom I, Andersson K, Jonasson K, Lindstedt G, Rybo G.
    Contraception; 1995 Sep; 52(3):175-9. PubMed ID: 7587189
    [Abstract] [Full Text] [Related]

  • 4. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
    Gao J, Zeng S, Sun BL, Wu SC, Dong J, Cong J, Zhu XH, Fan HM, Han LH, Xie Z.
    Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
    [Abstract] [Full Text] [Related]

  • 5. Quantitative studies on menstrual blood loss in IUD users.
    Andrade AT, Pizarro Orchard E.
    Contraception; 1987 Jul; 36(1):129-44. PubMed ID: 3311622
    [Abstract] [Full Text] [Related]

  • 6. [Menstrual blood loss and body iron stores: comparative study between a Multiload-375 IUD and a levonorgestrel vaginal ring].
    Souza JP, Andrade AT, Pizarro E.
    Bol Cent Biol Reprod; 1991 Jul; 10(1):26-32. PubMed ID: 12318141
    [Abstract] [Full Text] [Related]

  • 7. Effect of laparoscopic sterilization and insertion of Multiload Cu 250 and Progestasert IUDs on serum ferritin levels.
    Goh TH, Hariharan M.
    Contraception; 1983 Oct; 28(4):329-36. PubMed ID: 6667621
    [Abstract] [Full Text] [Related]

  • 8. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F, Perniola G, Mossa B, Marziani R, Perniola F, Stragapede B, Napolitano C.
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [Abstract] [Full Text] [Related]

  • 9. A longitudinal study of serum iron indices and haemoglobin concentration following copper-IUD insertion.
    Goh TH, Hariharan M, Tan CH.
    Contraception; 1980 Oct; 22(4):389-95. PubMed ID: 7449387
    [Abstract] [Full Text] [Related]

  • 10. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status.
    Larsson G, Milsom I, Lindstedt G, Rybo G.
    Contraception; 1992 Oct; 46(4):327-34. PubMed ID: 1486771
    [Abstract] [Full Text] [Related]

  • 11. Iron status in Danish women aged 35-65 years. Relation to menstruation and method of contraception.
    Milman N, Rosdahl N, Lyhne N, Jørgensen T, Graudal N.
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):601-5. PubMed ID: 8259744
    [Abstract] [Full Text] [Related]

  • 12. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO, Otolorin EO, Ladipo OA.
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [Abstract] [Full Text] [Related]

  • 13. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
    Malmqvist R, Petersohn L, Bengtsson LP.
    Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
    [Abstract] [Full Text] [Related]

  • 14. Consequences of uterine blood loss caused by various intrauterine contraceptive devices in South American women. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction.
    Andrade AT, Pizarro E, Shaw ST, Souza JP, Belsey EM, Rowe PJ.
    Contraception; 1988 Jul; 38(1):1-18. PubMed ID: 3048870
    [Abstract] [Full Text] [Related]

  • 15. Iron status in 268 Danish women aged 18-30 years: influence of menstruation, contraceptive method, and iron supplementation.
    Milman N, Clausen J, Byg KE.
    Ann Hematol; 1998 Jul; 77(1-2):13-9. PubMed ID: 9760147
    [Abstract] [Full Text] [Related]

  • 16. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M.
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [Abstract] [Full Text] [Related]

  • 17. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
    Faundes A, Alvarez F, Brache V, Tejada AS.
    Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
    [Abstract] [Full Text] [Related]

  • 18. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
    Andrade AT, Souza JP, Andrade GN, Rowe PJ, Wildemeersch D.
    Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
    [Abstract] [Full Text] [Related]

  • 19. Menstrual blood loss of TCu-380 A and TCu-200 B IUDs.
    El-sheikha Z, Hamza A, Mahmoud M.
    Popul Sci; 1990 Jul; ():55-62. PubMed ID: 12343358
    [Abstract] [Full Text] [Related]

  • 20. The effect of 1-year use of the CuT 380A and oral contraceptive pills on hemoglobin and ferritin levels.
    Hassan EO, el-Husseini M, el-Nahal N.
    Contraception; 1999 Aug; 60(2):101-5. PubMed ID: 10592857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.